Europe Clinical Nutrition Market

Europe Clinical Nutrition Market Size (2024 to 2032)

The size of the clinical nutrition market in Europe was worth USD 3.82 Billion in 2023 and is estimated to be growing at a CAGR of 7.17% from 2024 to 2032 and be worth USD 7.09 Billion by 2032 from USD 4.09 billion in 2024. The growth of the European clinical nutrition market is primarily driven by the aging population and increased disease diagnoses.

The growing number of people suffering from chronic diseases and metabolic disorders in the European region is propelling the European clinical nutrition market growth.

A recent survey shows approximately 35% of the EU population suffers from at least one chronic disease. Malnutrition is common in patients suffering from chronic diseases such as cancer, cardiovascular disease, diabetes, etc. Due to the increasing mortality rate, most patients prefer clinical nutrition, which helps to manage health conditions and reduce the symptoms of specific conditions by enabling a personalized diet. Clinical nutrition significantly prevents diseases like diabetes, heart-related disorder, and joint pain. During the weight loss process, nutritional intake is less. In such cases, nutritionists prefer to add clinical nutrition products to our diet, which is expected to favor the clinical nutrition market in Europe.

The growing geriatric population in Europe and the rising adoption of sedentary lifestyles are predicted to fuel the clinical nutrition market growth in Europe. Nutrition plays a significant role in the well-being of older people. However, the growing number of people suffering from infections in Europe, illnesses, and extended hospital stays will all lead to a reduced intake of nutritious foods into the body, resulting in more recovery time from the diseases. Furthermore, due to changing lifestyles, most people have become addicted to tobacco and alcohol, which reduce the body's nutritional levels and make people prone to different health issues.

The growing adoption of technological developments in the R&D and manufacturing of clinical nutrition products is projected to boost the European clinical nutrition market. Manufacturers are focused on the development of different types of nutritional products for different age groups of people. Using digital technology in clinical nutrition also helps with the market's demand. Artificial intelligence for diet optimization, food image recognition, risk prediction, and diet pattern analysis also help with clinical nutrition diet market growth.

On the other hand, a lack of awareness about clinical nutrition is the primary factor hindering the market growth. Additionally, the lack of skilled professionals in the laboratory, lack of reimbursement policies, and strict government regulation are the other factors that hamper the market growth.

This research report on the European clinical nutrition market has been segmented and sub-segmented into the following categories.

Europe Clinical Nutrition Market Analysis By Product Type

• Oral Nutrition

• Enteral Nutrition

• Parenteral Nutrition

The oral nutrition segment is predicted to capture a major share of the European clinical nutrition market during the forecast period.

Europe Clinical Nutrition Market Analysis By Therapeutic Areas 

• Malabsorption

• Diarrhea

• Cancer
• Food Allergies
• Maldigestion
• Diabetes
• Short-Bowel Syndrome
• Acute Lung Injury
• Acute Respiratory Distress

The diabetes segment is expected to play the leading role in the European clinical nutrition market during the forecast period.

Europe Clinical Nutrition Market Analysis By Ingredients Type 

• Vitamins

• Minerals

• Carbohydrates
• Amino Acids

Europe Clinical Nutrition Market Analysis By Country 

• UK

• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, the European region had the second largest share of the global market in 2023 and is expected to grow promisingly during the forecast period owing to the growing number of product launches and increasing awareness about clinical nutrition. In Europe, several training centers have been established for clinical nutrition for children suffering from various diseases from their childhood. Nutrition is the most critical factor for children’s growth, and every parent should take care of their children by providing sufficient nutrition in their diet. Due to the increasing demand for nutritional specialists, most healthcare providers are taking special courses regarding nutrition at the university, which is expected to promote the European market growth.

The UK clinical nutrition market is anticipated to hold a major share of the European market during the forecast period owing to the increasing number of online postgraduation courses for national courses. In addition, increasing awareness about nutrition intake by the population to lead a healthier lifestyle, most people are adopting clinical nutrition product which helps their body management.

Germany is another noteworthy market for clinical nutrition in Europe.

The growing clinical nutritional research in Europe also helps the growth of the market in the country. Due to the increasing number of research centers, key players are increasing investments leading to the development of clinical nutrition products for the population, which helps the market demand. Various types of clinical nutrient products are available in Germany at an affordable cost.

KEY MARKET PLAYERS

Notable companies operating in the Europe Clinical Nutrition Market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H. J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.